Disinhibition and glutamate: extending the latent phenotype model (360G-Wellcome-110049_Z_15_A)
Funding Organization
£245,788
Recipient Organization
Not available
Where is this data from?
This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.
Grant Details
| Amount Awarded | 245788 |
| Applicant Surname | Chamberlain |
| Approval Committee | Internal Decision Panel |
| Award Date | 2020-09-30T00:00:00+00:00 |
| Financial Year | 2019/20 |
| Grant Programme: Title | Intermediate Clinical Fellowship |
| Internal ID | 110049/Z/15/A |
| Lead Applicant | Prof Samuel Chamberlain |
| Partnership Value | 245788 |
| Planned Dates: End Date | 2022-02-02T00:00:00+00:00 |
| Planned Dates: Start Date | 2021-02-03T00:00:00+00:00 |
| Recipient Org: Country | United Kingdom |
| Region | East of England |